Glycemic Optimization On Discharge From the Emergency Room
NCT ID: NCT05197829
Last Updated: 2024-04-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2022-01-05
2024-01-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Inpatient Diabetes Mellitus (DM) Management With Continuous Glucose Monitoring Devices, a Pilot Study.
NCT02904512
Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA)
NCT05439928
Continuous Glucose Monitoring in Hospitalized Patients With Diabetes Mellitus
NCT04653454
Continuous Glucose Monitoring of Hospitalized Patients With Diabetes
NCT04230694
Effect of the Use of Continuous Glucose Monitoring Versus Standard Glycemic Control in Hospitalized Patients with Type 2 Diabetes.
NCT06607224
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continuous Glucose Monitoring
Continuous Glucose Monitoring
Participants in the experimental arm will receive an unblinded flash continuous glucose monitor.
Care Coordination
All participants will receive diabetes education, written handouts, and help setting up ambulatory appointments.
Care Coordination
Care Coordination
All participants will receive diabetes education, written handouts, and help setting up ambulatory appointments.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous Glucose Monitoring
Participants in the experimental arm will receive an unblinded flash continuous glucose monitor.
Care Coordination
All participants will receive diabetes education, written handouts, and help setting up ambulatory appointments.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Either an existing diabetes center patient or a new referral
* Type 1 or type 2 diabetes
* Able to provide informed consent
* Fluent in English or Spanish
Exclusion Criteria
* Need for hospital admission
* Upcoming CT or MRI within 2 weeks
* Pregnancy
* Altered mental status
* Not appropriate for diabetes center follow up
* Prisoners
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mark O'Connor
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mark O'Connor
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mark J O'Connor, MD
Role: PRINCIPAL_INVESTIGATOR
University of Massachusetts, Worcester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UMass Memorial Medical Center
Worcester, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H00023559
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.